Additional less common molecular alterations seen almost exclusively in the SCLC-like LCNEC included PTEN mutations and MYCL1 amplification, and those seen exclusively in the NSCLC-like LCNEC involved MAP2K1, ERBB2, BRAF, and CDKN2A genes. Here, MYCL is linked to large cell neuroendocrine carcinoma.